Pharma Launches “Ozempic For Cats” Study [VIDEO]

CBS News reports: Popular GLP-1 weight loss drugs could soon be available for pets. Okava Pharmaceuticals, based in San Francisco, just launched MEOW-1 — a clinical study that utilizes a tiny, under-the skin implant in 50 cats to release a GLP-1 medication drug over six months. It has the potential to enhance cats’ quality of […]

Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue

Quick Read Pfizer (PFE) posted Q3 revenue of $16.65B down 5.9% as COVID products declined sharply. Paxlovid dropped 55% and Comirnaty fell 20%. Teva (TEVA) delivered its 11th consecutive quarter of growth with revenue up 3.4% to $4.48B. AUSTEDO surged 38% to $618M and drove the innovative portfolio expansion. Teva crushed EPS estimates by 16% […]

Can Weight-Loss Drugs Be Fair in Sports? Serena Williams Just Raised the Stakes

An earthquake shook the sporting universe this week: Serena Williams, the 23-time Grand Slam tennis champion, has taken the first step toward a potential comeback by reentering the sport’s anti-doping test pool. After news reports surfaced on Tuesday of her registration with the International Tennis Integrity Agency, Williams tried to quell speculation about a potential […]

10 Weekend Reads

The weekend is here! Pour yourself a mug of Danish Blend coffee, grab a seat outside, and get ready for our longer-form weekend reads: • In the Shadow of Jane Street and Citadel Securities, Hudson River Mints Billions: The quiet flash boy has morphed into a powerhouse among non-bank market makers. (Bloomberg free) • In every corner […]

Food Exec Brief: AI Velocity, GLP-1 Disruption, and Manufacturing’s Autonomous Future

Welcome to this week’s Food Exec Brief, your strategic intelligence roundup covering the accelerating deployment of AI across R&D and operations, the seismic impact of GLP-1 medications on consumer behavior, and the convergence of automation and sustainability reshaping competitive dynamics in food and beverage manufacturing. Key takeaways: AI moves from novelty to necessity: Food giants […]